-
Policy Interpretation of the National Medical Products Administration on Issuing the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers
2025-12-24
In order to implement the spirit of "Supporting the Export Trade of Drugs and Medical Devices" outlined in the Opinions of the General Office of the State Council on Comprehensively Deepening the Reform of the Regulation of Drugs and Medical Devices to Promote the High-Quality Development of the Pharmaceutical Industry (GBF [2024] No. 53), the National Medical Products Administration (NMPA) has formulated the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers, (hereinafter referred to as the "Provisions").
-
Announcement of the National Medical Products Administration on Issuing the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers([2025] No. 113)
2025-12-24
In order to support the export trade of pharmaceutical products and strengthen the management of inspection and export certificate for exported pharmaceutical products of pharmaceutical manufacturers, the National Medical Products Administration has formulated the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers, which is hereby promulgated and shall come into force as of January 1, 2026.
-
Revision and Release of the Good Manufacturing Practice for Medical Devices
2025-12-24
On November 4, the National Medical Products Administration (NMPA) released the revised version of the Good Manufacturing Practice for Medical Devices (hereinafter referred to as the GMP). The new GMP for medical devices shall come into effect as of November 1, 2026.
-
Requirements for the Pilot Program of Electronic Labels for Cosmetics
2025-12-24
To regulate the pilot program for electronic labels for cosmetics (including toothpaste, hereinafter referred to as "cosmetics"), these Requirements are formulated in accordance with the provisions of the Regulations on Supervision and Administration of Cosmetics (hereinafter referred to as the "Regulations"), the Provisions for Registration and Filing of Cosmetics, the Provisions for Supervision and Administration of Manufacturing and Marketing of Cosmetics, the Provisions for Toothpaste Regulation, and the Measures for the Administration of Cosmetics Labels.
-
Announcement of the National Medical Products Administration on the Release of the Good Manufacturing Practice for Medical Devices ([2025] No. 107)
2025-12-24
To strengthen the quality management of medical device manufacturing, regulate medical device manufacturing activities, promote normative development of the industry, and ensure the safety and effectiveness of medical devices for public use, the National Medical Products Administration has revised the Good Manufacturing Practice for Medical Devices in accordance with the Regulations for the Supervision and Administration of Medical Devices and the Provisions for Supervision and Administration of Medical Device Manufacturing.
-
NMPA holds meeting to review QMS in vaccine regulation, pharmaceutical manufacturing inspection
2025-07-21
The National Medical Products Administration (NMPA) held a meeting on June 9 to conduct the 2024 annual review of the quality management system (QMS) in vaccine regulation and pharmaceutical manufacturing inspection. NMPA Commissioner Li Li chaired the meeting and fully affirmed the suitability, adequacy, and effectiveness of the NMPA's QMS in these two areas.
